Serine/threonine-protein kinase N3 (EC 2.7.11.13) (Protein kinase PKN-beta) (Protein-kinase C-related kinase 3)
1_MEEGA 6_ PRQPG 11_ PSQWP 16_ PEDEK 21_ EVIRR 26_ AIQKE 31_ LKIKE 36_ GVENL 41_ RRVAT 46_ DRRHL 51_ GHVQQ 56_ LLRSS 61_ NRRLE 66_ QLHGE 71_ LRELH 76_ ARILL 81_ PGPGP 86_ GPAEP 91_ VASGP 96_ RPWAE 101_ QLRAR 106_ HLEAL 111_ RRQLH 116_ VELKV 121_ KQGAE 126_ NMTHT 131_ CASGT 136_ PKERK 141_ LLAAA 146_ QQMLR 151_ DSQLK 156_ VALLR 161_ MKISS 166_ LEASG 171_ SPEPG 176_ PELLA 181_ EELQH 186_ RLHVE 191_ AAVAE 196_ GAKNV 201_ VKLLS 206_ SRRTQ 211_ DRKAL 216_ AEAQA 221_ QLQES 226_ SQKLD 231_ LLRLA 236_ LEQLL 241_ EQLPP 246_ AHPLR 251_ SRVTR 256_ ELRAA 261_ VPGYP 266_ QPSGT 271_ PVKPT 276_ ALTGT 281_ LQVRL 286_ LGCEQ 291_ LLTAV 296_ PGRSP 301_ AAALA 306_ SSPSE 311_ GWLRT 316_ KAKHQ 321_ RGRGE 326_ LASEV 331_ LAVLK 336_ VDNRV 341_ VGQTG 346_ WGQVA 351_ EQSWD 356_ QTFVI 361_ PLERA 366_ RELEI 371_ GVHWR 376_ DWRQL 381_ CGVAF 386_ LRLED 391_ FLDNA 396_ CHQLS 401_ LSLVP 406_ QGLLF 411_ AQVTF 416_ CDPVI 421_ ERRPR 426_ LQRQE 431_ RIFSK 436_ RRGQD 441_ FLRAS 446_ QMNLG 451_ MAAWG 456_ RLVMN 461_ LLPPC 466_ SSPST 471_ ISPPK 476_ GCPRT 481_ PTTLR 486_ EASDP 491_ ATPSN 496_ FLPKK 501_ TPLGE 506_ EMTPP 511_ PKPPR 516_ LYLPQ 521_ EPTSE 526_ ETPRT 531_ KRPHM 536_ EPRTR 541_ RGPSP 546_ PASPT 551_ RKPPR 556_ LQDFR 561_ CLAVL 566_ GRGHF 571_ GKVLL 576_ VQFKG 581_ TGKYY 586_ AIKAL 591_ KKQEV 596_ LSRDE 601_ IESLY 606_ CEKRI 611_ LEAVG 616_ CTGHP 621_ FLLSL 626_ LACFQ 631_ TSSHA 636_ CFVTE 641_ FVPGG 646_ DLMMQ 651_ IHEDV 656_ FPEPQ 661_ ARFYV 666_ ACVVL 671_ GLQFL 676_ HEKKI 681_ IYRDL 686_ KLDNL 691_ LLDAQ 696_ GFLKI 701_ ADFGL 706_ CKEGI 711_ GFGDR 716_ TSTFC 721_ GTPEF 726_ LAPEV 731_ LTQEA 736_ YTRAV 741_ DWWGL 746_ GVLLY 751_ EMLVG 756_ ECPFP 761_ GDTEE 766_ EVFDC 771_ IVNMD 776_ APYPG 781_ FLSVQ 786_ GLEFI 791_ QKLLQ 796_ KCPEK 801_ RLGAG 806_ EQDAE 811_ EIKVQ 816_ PFFRT 821_ TNWQA 826_ LLART 831_ IQPPF 836_ VPTLC 841_ GPADL 846_ RYFEG 851_ EFTGL 856_ PPALT 861_ PPAPH 866_ SLLTA 871_ RQQAA 876_ FRDFD 881_FVSER
1: Contributes to invasiveness in malignant prostate cancer